Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteScienzaWeb e Social Network

32 comunicati stampa

Guarda tutti i comunicati
10/03/2026
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
04/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
26/02/2026
Organizzazione Aziendale
Salute
Fitness
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
25/02/2026
Industria
Salute
Scienza
Farmaceutica
Biotecnologia
Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
06/02/2026
Biotecnologia
Salute
Fitness
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
15/01/2026
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
22/12/2025
Luxury
Pubblico Esercizio/Vendita al dettaglio
Accessori
Sanità
Salute
Cosmesi
Scienza
Mercato azionario
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
13/11/2025
Multimedialità
Cosmesi
E-commerce
Pubblico Esercizio/Vendita al dettaglio
Luxury
Salute
Industria
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
13/11/2025
Scienza
Psichiatria
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Industria
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
06/11/2025
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Finanza
Niagen Bioscience Announces $10 Million Share Repurchase Program
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0